Safety profile of mycophenolate mofetil

被引:5
作者
Basara, N [1 ]
Fauser, AA [1 ]
机构
[1] Clin Bone Marrow Transplantat & Haematol Oncol, D-55743 Idar Oberstein, Germany
关键词
D O I
10.1038/sj.bmt.1702723
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:1362 / 1363
页数:2
相关论文
共 9 条
[1]   Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient [J].
Basara, N ;
Blau, WI ;
Kiehl, MG ;
Römer, E ;
Rudolphi, M ;
Bischoff, M ;
Kirsten, D ;
Sanchez, H ;
Günzelmann, S ;
Fauser, AA .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (08) :4087-4089
[2]   Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients [J].
Basara, N ;
Blau, WI ;
Römer, E ;
Rudolphi, M ;
Bischoff, M ;
Kirsten, D ;
Sanchez, H ;
Günzelmann, S ;
Fauser, AA .
BONE MARROW TRANSPLANTATION, 1998, 22 (01) :61-65
[3]   Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients [J].
Basara, N ;
Blau, WI ;
Kiehl, MG ;
Schmetzer, B ;
Bischoff, M ;
Kirsten, D ;
Günzelmann, S ;
Fauser, AA .
CLINICAL TRANSPLANTATION, 2000, 14 (02) :121-126
[4]   Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation [J].
Bornhäuser, M ;
Schuler, U ;
Pörksen, G ;
Naumann, R ;
Geissler, G ;
Thiede, C ;
Schwerdtfeger, R ;
Ehninger, G ;
Thiede, HM .
TRANSPLANTATION, 1999, 67 (04) :499-504
[5]   Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation [J].
Busca, A ;
Saroglia, EM ;
Lanino, E ;
Manfredini, L ;
Uderzo, C ;
Nicolini, B ;
Messina, C ;
Rabusin, M ;
Miniero, R .
BONE MARROW TRANSPLANTATION, 2000, 25 (10) :1067-1071
[6]   Adverse effects of mycophenolate mofetil in pediatric renal transplant recipients with presumed chronic rejection [J].
Butani, L ;
Palmer, J ;
Baluarte, HJ ;
Polinsky, MS .
TRANSPLANTATION, 1999, 68 (01) :83-86
[7]  
Keown P, 1996, TRANSPLANTATION, V61, P1029
[8]   Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus [J].
Mookerjee, B ;
Altomonte, V ;
Vogelsang, G .
BONE MARROW TRANSPLANTATION, 1999, 24 (05) :517-520
[9]   MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL-ALLOGRAFT RECIPIENTS [J].
SOLLINGER, HW .
TRANSPLANTATION, 1995, 60 (03) :225-232